Blisovi 24 Fe Kit
Product Images NDC 68180-864

12 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Blisovi 24 Fe (NDC 68180-864). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (934a273b 4e1e 4b97 972f 71cdf6be0e05 01)

1 (934a273b 4e1e 4b97 972f 71cdf6be0e05 01)
A forest plot showing effect estimates (odds ratios/relative risks) with 95% confidence intervals for multiple studies related to contraceptive use. Each study is listed by name and year, with markers and horizontal lines indicating effect size and confidence intervals ranging from approximately 0.5 to 2.0.*
FDA Label Image

Image-1 (934a273b 4e1e 4b97 972f 71cdf6be0e05 02)

Image-1 (934a273b 4e1e 4b97 972f 71cdf6be0e05 02)
Chemical structure of the active ingredient shown on the product Blisovi 24 Fe by Lupin Pharmaceuticals, Inc. The structure features a steroid backbone with a hydroxyl group, a methyl group, and an ethynyl group attached.*
FDA Label Image

Image-2 (934a273b 4e1e 4b97 972f 71cdf6be0e05 03)

Image-2 (934a273b 4e1e 4b97 972f 71cdf6be0e05 03)
Chemical structure diagram of the active ingredient in Blisovi 24 Fe, showing a steroidal framework with labeled carbon, hydrogen, oxygen atoms, and a characteristic acetylene group.*
FDA Label Image

Image-2 (934a273b 4e1e 4b97 972f 71cdf6be0e05 04)

Image-2 (934a273b 4e1e 4b97 972f 71cdf6be0e05 04)
A line graph depicting Norethindrone concentration (pg/mL) over time (hours) for Blisovi 24 Fe. Two curves are shown: Day 1 (solid circles) and Day 24 (open circles), with concentration peaking early and declining over 24 to 60 hours, illustrating the pharmacokinetic profile over these time points.*
FDA Label Image

Image-4 (934a273b 4e1e 4b97 972f 71cdf6be0e05 05)

Image-4 (934a273b 4e1e 4b97 972f 71cdf6be0e05 05)
A line graph showing Ethinyl Estradiol concentration (pg/mL) over time (hours) with two curves for Day 1 and Day 24. The graph illustrates the concentration peaks and decline of Ethinyl Estradiol within a 60-hour period.*
FDA Label Image

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 06)

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 06)
This image shows a trademark statement indicating that LUPIN and a logo are registered trademarks of Lupin Pharmaceuticals, Inc. This is a text excerpt typically found in product labeling or inserts.*
FDA Label Image

Image-5 (934a273b 4e1e 4b97 972f 71cdf6be0e05 07)

Image-5 (934a273b 4e1e 4b97 972f 71cdf6be0e05 07)
A chart depicting pregnancy rates per 100 women in one year with different birth control methods. It categorizes methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring) to more pregnancies (no birth control), illustrating relative pregnancy risk alongside method types.*
FDA Label Image

Image-6 (934a273b 4e1e 4b97 972f 71cdf6be0e05 08)

Image-6 (934a273b 4e1e 4b97 972f 71cdf6be0e05 08)
An instructional diagram for Blisovi 24 Fe showing a 28-day pill pack layout with circles representing daily pills arranged by day from Sunday to Saturday across four weeks. It includes directions for Day-1 starters to align the day label strip based on the first day of their period, with arrows indicating the sequence of pill intake starting at Sunday.*
FDA Label Image

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 09)

FDA Label Image

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 10)

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 10)
Blisovi 24 Fe lidding foil label showing active ingredients norethindrone acetate and ethinyl estradiol tablets USP with ferrous fumarate tablets, strength 1 mg/0.02 mg. The label displays storage instructions, barcode, labeler Lupin Pharmaceuticals, Inc. (Naples, FL), and manufacturer Lupin Limited (India). It also includes a monthly self breast exam reminder.*
FDA Label Image

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 11)

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 11)
Blisovi 24 Fe tablets packaging label by Lupin Pharmaceuticals, Inc. The label shows the product name and active ingredients: norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets. The strength is 1 mg/0.02 mg. The package contains 1 blister of 28 tablets, providing 24 days of active therapy. Additional regulatory and usage information is printed on the label.*
FDA Label Image

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 12)

Image (934a273b 4e1e 4b97 972f 71cdf6be0e05 12)
Blisovi 24 Fe 1 mg/0.02 mg tablets packaging label from Lupin Pharmaceuticals, Inc. The label indicates the product contains norethindrone acetate and ethinyl estradiol tablets USP plus ferrous fumarate tablets. It includes 3 blisters of 28 tablets each, providing 24 days of active therapy. The label also states distribution by Lupin Pharmaceuticals, Naples, FL, and manufacture by Lupin Limited, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.